Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2217/fon-2019-0461 | DOI Listing |
Lasers Med Sci
June 2024
Department of Dermatology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Cancers (Basel)
September 2023
Department of Oral Medicine, Sedation and Imaging, Faculty of Dental Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem 9112001, Israel.
(1) Background: Immunotherapy-related adverse effects (irAEs) have been reported to manifest in oral tissues, mainly as lichenoid and non-lichenoid lesions and salivary gland dysfunction; however, the characterization of oral irAEs and their clinical impact is limited. (2) Methods: This is a retrospective clinical chart review of 14 patients with oral irAEs, describing the impact of the oral irAEs in terms of the immediate effect, treatment, chronicity of the irAEs and the development of oral cancer. (3) Results: Common symptoms were pain and dry mouth, causing no-to-severe pain and/or dry mouth sensation.
View Article and Find Full Text PDFJ Pers Med
November 2020
Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Although they cannot be considered curative, the new therapeutic integrated advances in metastatic breast cancer (MBC) have substantially improved patient outcomes. Traditionally, surgery was confined to palliation of symptomatic or ulcerating lumps. Data suggest, in some cases, a possible additive role for more aggressive locoregional surgical therapy in combination with systemic treatments in the metastatic setting, although a low level of evidence has been shown in terms of improvement in overall survival in MBC patients treated with surgery and medical treatment compared to medical treatment alone.
View Article and Find Full Text PDFPhotobiomodul Photomed Laser Surg
April 2020
Companion Animal Health, LiteCure LLC, New Castle, Delaware, USA.
The objective of this retrospective review was to examine the impact that adding photobiomodulation therapy (PBMt) to rehabilitation therapy had on the pathology of degenerative myelopathy (DM) in canine patients. Canine DM is a progressive, fatal neurodegenerative disease for which there exists a dearth of effective treatments, limiting clinicians to pursue symptom palliation. Clinical records of dogs referred for presumed DM to a specialty rehabilitation facility were screened for patients meeting study criteria.
View Article and Find Full Text PDFFuture Oncol
November 2019
Department of Oral Medicine, Oral & Maxillofacial Center, Medical Corps, Israel Defense Forces; & Oral Medicine Clinic for Hematologic & Oncologic Patients, Department of Oral Medicine, Sedation & Maxillofacial Imaging, Hebrew University-Hadassah School of Dental Medicine, Jerusalem 9112102, Israel.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!